Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-06-09 2:15 pm Purchase | 2023-05-31 | 13G | IONIS PHARMACEUTICALS INC IONS | VANGUARD GROUP INC | 14,414,917 10.070% | 868,223 (+6.41%) | Filing History |
| 2023-02-14 4:07 pm Sale | 2022-12-31 | 13G | IONIS PHARMACEUTICALS INC IONS | BB BIOTECH AG | 9,635,000 6.800% | -597,973 (-5.84%) | Filing History |
| 2023-02-14 12:40 pm Purchase | 2022-12-31 | 13G | IONIS PHARMACEUTICALS INC IONS | T. Rowe Price Investment Management, Inc. | 11,678,259 8.200% | 11,678,259 (New Position) | Filing History |
| 2023-02-09 11:22 am Purchase | 2022-12-30 | 13G | IONIS PHARMACEUTICALS INC IONS | VANGUARD GROUP INC | 13,546,694 9.540% | 1,539,618 (+12.82%) | Filing History |
| 2023-02-09 11:18 am Purchase | 2023-02-09 | 13G | IONIS PHARMACEUTICALS INC IONS | FMR LLC | 21,307,519 14.999% | 126,017 (+0.59%) | Filing History |
| 2023-01-31 5:52 pm Purchase | 2022-12-31 | 13G | IONIS PHARMACEUTICALS INC IONS | BlackRock, Inc. BLK | 9,182,911 6.500% | 643,629 (+7.54%) | Filing History |
| 2022-08-10 2:56 pm Sale | 2022-07-31 | 13G | IONIS PHARMACEUTICALS INC IONS | T. Rowe Price Associates, Inc. | 4,808,770 3.300% | -9,541,690 (-66.49%) | Filing History |
| 2022-04-11 11:13 am Purchase | 2022-03-31 | 13G | IONIS PHARMACEUTICALS INC IONS | T. Rowe Price Associates, Inc. | 14,350,460 10.100% | 1,860,180 (+14.89%) | Filing History |
| 2022-02-14 2:34 pm Sale | 2021-12-31 | 13G | IONIS PHARMACEUTICALS INC IONS | T. Rowe Price Associates, Inc. | 12,490,280 8.800% | -624,687 (-4.76%) | Filing History |
| 2022-02-11 4:42 pm Purchase | 2021-12-31 | 13G | IONIS PHARMACEUTICALS INC IONS | BB BIOTECH AG | 10,232,973 7.200% | 2,012,973 (+24.49%) | Filing History |
| 2022-02-10 08:17 am Sale | 2021-12-31 | 13G | IONIS PHARMACEUTICALS INC IONS | VANGUARD GROUP INC | 12,007,076 8.500% | -237,312 (-1.94%) | Filing History |
| 2022-02-09 12:27 pm Purchase | 2021-12-31 | 13G | IONIS PHARMACEUTICALS INC IONS | ARK Investment Management LLC | 7,083,256 5.020% | 7,083,256 (New Position) | Filing History |
| 2022-02-09 09:19 am Purchase | 2022-02-08 | 13G | IONIS PHARMACEUTICALS INC IONS | FMR LLC | 21,181,502 14.999% | 201,780 (+0.96%) | Filing History |
| 2022-02-01 5:08 pm Sale | 2021-12-31 | 13G | IONIS PHARMACEUTICALS INC IONS | BlackRock, Inc. BLK | 8,539,282 6.000% | -1,211,220 (-12.42%) | Filing History |